South Africa – The Value of a Patent in South Africa (Bayer Intellectual Property GmbH et al v Austell Pharmaceuticals (Pty) Ltd 20 May 2021 CCP

CLICK HERE TO VIEW JUDGEMENT

On 20 May 2021, the South African Patents Court confirmed the rights of a patentee in interim interdict proceedings in circumstances where the patent claim included a non-essential integer.

In this matter, and despite the constraints caused by the Covid-19 pandemic, detailed and voluminous affidavit evidence from various parties in different countries and lengthy legal argument, Bayer was able to obtain an interim interdict within less than 4 months of the launch of generic pharmaceutical being sold by the Austel Pharmaceuticals under the brand name, Rezalto.  This judgment confirms the value of a valid patent in South Africa and engenders confidence in the functioning of the South African intellectual property, legal and judicial systems.

Source:  PDF attached; 20210520 Bayer v Austel – Commissioner of Patents Judgement ZA2007-06238 – 20 May 2021 – OCR

View Related Blogs
View All
news

Your Brand, Their Domain: What Can You Do?

Understanding Domain Name Disputes in South Africa Your Domain Name Is More Than Just a Web Address Put simply, a domain name is the unique online address used to find a website. For example, yourbusi...

Amina SulimanIntellectual PropertyTrade Marks
news

Plant health rules become a passport to agricultural markets

Plant health regulation on the continent became more closely tied to agricultural market access during the quarter. South Africa prepared to implement a new Plant Health Act, expanding inspection, qua...

Adams NewsAfrica Ip updatesSouth Africa
news

South Africa opens ARC vaccine IP to private manufacturing

South Africa opened a new commercial route for public agricultural biotechnology in September when the Agricultural Research Council (ARC) approved conditional licensing of its foot-and-mouth disease ...

Adams NewsAfrica Ip updatesSouth Africa